MRI versus clinical relapses as a measure of disease activity in MS

International MS Journal

Volumn 7, Issue 3, 2000, Pages 88-90

  Polman, C ^a   Pozilli, C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER;

CLINICAL EXAMINATION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; HUMAN; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT MONITORING; PRESCRIPTION; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; RISK BENEFIT ANALYSIS; SHORT SURVEY;

EID: 0034467760     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and change in disability or impairment in multiple sclerosis: A meta-analysis
2. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis. Relation to inflammatory activity
3. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
4. The role of magnetic resonance techniques in understanding and managing multiple sclerosis
5. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
6. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
7. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis
8. Quantitative MRI changes in gadolinium-DTPA after high dose intravenous methylprednisolone treatment in multiple sclerosis
9. The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: A longitudinal MRI study in relapsing-remitting multiple sclerosis patients
10. Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta 1a
11. Magnetic resonance imaging changes with recombinant human interferon beta 1a: A short term in relapsing-remitting multiple sclerosis
12. Clinical worsening multiple sclerosis is associated with increased frequency and area of gadopentate dimeglumine-enhancing magnetic resonance imaging lesions
13. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis
14. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis
15. Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance imaging study
16. Multisequence MRI in clinically isolated syndromes and the early development of MS
17. Axonal transection in the lesions of multiple sclerosis